BVF Partners OS Ltd. is 10% Owner at INFINITY PHARMACEUTICALS, INC. (INFI). They have made 12 open-market trades across 10 companies since 2017, most recently 2025-01-10.
CIK 0001660684
11 open-market purchases totalling $61.6M since 2017, against 1 sale. Across 9 scored buys the stock is up 6.6% at ninety days, and 3.2 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 55% | 22% |
| Avg Move | +1.7% | +2.4% | +6.6% |
| Alpha | +0.8% | +1.0% | +3.2% |
| Scored | 11 | 11 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RAIN | BUY | 2021-05-13 | 2021-05-17 | $14.26 | $1.6M | +21.0% | +13.4% | -3.2% |
| MRUS | BUY | 2021-01-21 | 2021-01-25 | $24.75 | $33.3M | -18.2% | -33.0% | -24.6% |
| XOMA | BUY | 2020-09-21 | 2020-09-23 | $18.33 | $1.8M | +5.3% | +22.6% | +147.0% |
| IDYA | BUY | 2020-06-19 | 2020-06-22 | $14.32 | $3.4M | -3.5% | -6.4% | -14.5% |
| FPRX | BUY | 2019-12-20 | 2019-12-26 | $4.05 | $4.2M | +2.6% | +7.6% | -49.0% |
| PIRS | SELL | 2019-09-06 | 2019-09-10 | $4.50 | $225K | +8.7% | -41.2% | -38.5% |
| INFI | BUY | 2018-11-13 | 2018-11-15 | $1.35 | $2.4M | -8.7% | -21.3% | -10.7% |
| INFI | BUY | 2018-04-09 | 2018-04-11 | $1.95 | $3.9M | +5.8% | -2.9% | -3.8% |
| CNCE | BUY | 2017-10-19 | 2017-10-23 | $15.84 | $10.5M | +6.2% | +38.4% | +22.7% |
| XENE | BUY | 2017-06-27 | 2017-06-29 | $4.00 | $342K | +4.8% | -1.6% | -4.8% |
| NVLS | BUY | 2017-06-20 | 2017-06-22 | $2.25 | $40K | +3.0% | +3.4% | N/A |
| NVLS | BUY | 2017-06-05 | 2017-06-07 | $2.28 | $166K | +0.0% | +6.6% | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CNCE | 291,788 | $2.4M |
| NVLS | 201,811 | $1.9M |
| RAIN | 555,105 | $345K |
| INFI | 7,474,110 | $334K |
| Total | $590.3M |
Shares reported on the most recent Form 4, priced at the 2025-01-14 close.